Compare TAK & ASX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TAK | ASX |
|---|---|---|
| Founded | 1781 | 1984 |
| Country | Japan | Taiwan |
| Employees | 47455 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 48.4B |
| IPO Year | N/A | 2000 |
| Metric | TAK | ASX |
|---|---|---|
| Price | $17.86 | $21.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 2.4M | ★ 8.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.97% | 1.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.04 | $18.75 |
| Revenue Next Year | $0.92 | $15.20 |
| P/E Ratio | $41.25 | ★ $38.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $7.53 |
| 52 Week High | $18.82 | $25.29 |
| Indicator | TAK | ASX |
|---|---|---|
| Relative Strength Index (RSI) | 49.07 | 42.79 |
| Support Level | $14.78 | $9.63 |
| Resistance Level | $18.82 | $24.33 |
| Average True Range (ATR) | 0.24 | 0.74 |
| MACD | -0.18 | -0.49 |
| Stochastic Oscillator | 26.30 | 3.50 |
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, Packaging segment contribute the maximum revenue. The packaging segment involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufactures, and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.